# Siemens Healthineers Spins Off In Vitro Diagnostics Unit as Olyrian Diagnostics

Siemens Healthineers will carve out its in vitro diagnostics (IVD) business as a standalone company. The new entity will operate under the name Olyrian Diagnostics. The announcement includes a rebranding of the diagnostics segment. No timeline for the carve-out or additional details on leadership or financial terms were provided.

In vitro diagnostics are used to analyze patient samples such as blood, urine, or tissue for disease detection, monitoring, and treatment guidance. These tools are foundational in clinical medicine, public health surveillance, and biomedical research. Separating the IVD business into a dedicated company may allow for more focused investment and innovation in diagnostic technologies. Such restructuring is common in the life-sciences industry as large healthcare firms aim to sharpen strategic focus and respond to evolving market demands.

Source: [original report](https://www.fiercebiotech.com/medtech/siemens-healthineers-rebrands-and-carves-out-vitro-diagnostics-biz)